How to cite item

Lenvatinib/Pembrolizumab as second line treatment for advanced melanoma patients refractory to programmed death 1 (PD-1)/programmed death ligand-1 (PD-L1) inhibitors

   
@article{ATM110234,
	author = {Pier Francesco Ferrucci},
	title = {Lenvatinib/Pembrolizumab as second line treatment for advanced melanoma patients refractory to programmed death 1 (PD-1)/programmed death ligand-1 (PD-L1) inhibitors},
	journal = {Annals of Translational Medicine},
	volume = {11},
	number = {8},
	year = {2023},
	keywords = {},
	abstract = {},
	issn = {2305-5847},	url = {https://atm.amegroups.org/article/view/110234}
}